Five Pawns Meets FDA's E-Liquid Manufacturer Registration Requirements Ahead of Deadline

We are extremely proud to announce that we have received confirmation from the FDA that the federal agency has accepted our filing to continue to manufacture and sell the complete line of Five Pawns premium e-liquids in the US. Our documentation to the FDA was filed on December 19, 2016, demonstrating our intention to fully comply weeks prior to the filing deadline. Executing on the FDA's requirements is mandatory for all companies that wish to continue to manufacture and sell tobacco and related products in the US, and we have kept our promise to complete any necessary steps to continue providing high-quality vape products. “This is just the next logical step in our company's pledge to lead the industry by example. Five Pawns views this phase of the FDA compliance process as a continuation of our promise to be the global e-liquid brand of choice ‘then, now and forever' for our customers and partners alike,” explains Rodney Jerabek, CEO of Five Pawns Inc. Read the full press release for more information.

Full press release here.